Article thumbnail

Immunohistochemical localization of transforming growth factor β-1 and its relationship with collagen expression in advanced liver fibrosis due to biliary atresia

By Christian Farrington, Don Novak, Chen Liu and Allah B Haafiz
Topics: Original Research
Publisher: Dove Medical Press
OAI identifier: oai:pubmedcentral.nih.gov:3108674
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2007). A novel lipid-based drug carrier targeted to the non-parenchymal cells, including hepatic stellate cells, in the fibrotic livers of bile duct ligated rats. Biochim Biophys Acta.
  2. A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.
  3. Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B.
  4. Antifibrogenic effects of canrenone, an antialdosteronic drug, on human hepatic stellate cells.
  5. Antioxidant enzyme status in biliary obstructed rats: effects of N-acetylcysteine.
  6. (1986). Bile acid-induced liver toxicity: relation to the hydrophobic-hydrophilic balance of bile acids. Med Hypotheses.
  7. Bile acids induce hepatic stellate cell proliferation via activation of the epidermal growth factor receptor.
  8. (2001). Biliary atresia: an update on our understanding of the disorder. Curr Opin Pediatr.
  9. Contribution of hepatic parenchymal and nonparenchymal cells to hepatic fibrogenesis in biliary atresia.
  10. Determination of bile acids in needle biopsies of human liver.
  11. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study.
  12. Elevation of serum interleukin-18 levels and activation of Kupffer cells in biliary atresia.
  13. (2007). Evolving concepts of liver fibrogenesis provide new diagnostic and therapeutic options. Comp Hepatol.
  14. (1987). Expression and secretion of type beta transforming growth factor by activated human macrophages.
  15. Expression of collagens type I and IV, osteonectin and transforming growth factor beta-1 (TGFbeta1) in biliary atresia and paucity of intrahepatic bile ducts during infancy.
  16. (1989). Expression of transforming growth factor-beta 1 in specific cells and tissues of adult and neonatal mice.
  17. Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition.
  18. Glucocorticoids decrease the bioavailability of TGF-beta which leads to a reduced TGF-beta signaling in hepatic stellate cells.
  19. (1995). Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions.
  20. Hepatic fibrosis and survival in biliary atresia.
  21. Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers.
  22. Hepatic stellate cells and liver fibrosis.
  23. Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasis.
  24. Histological outcome during long-term lamivudine therapy.
  25. Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis
  26. Increased expression of connective tissue growth factor in fibrotic human liver and in activated hepatic stellate cells.
  27. interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group.
  28. Liver extracellular matrix in health and disease.
  29. Liver fibrosis in biliary atresia.
  30. (2009). Liver fibrosis staging with contrast-enhanced ultrasonography: prospective multicenter study compared with METAVIR scoring. Eur Radiol.
  31. Liver fibrosis.
  32. (1996). Macroscopic appearance at portoenterostomy – a prognostic variable in biliary atresia. J Pediatr Surg.
  33. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury.
  34. Outcome after portoenterostomy in biliary atresia: pivotal role of degree of liver fibrosis and intensity of stellate cell activation.
  35. (2008). Pentacam tomograms: a novel method for quantification of posterior capsule opacification. Invest Ophthalmol Vis Sci.
  36. Prediction of progressive liver fibrosis in hepatitis C infection by serum and tissue levels of transforming growth factor-beta.
  37. Suppression of stellate cell type I collagen gene expression involves AP-2 transmodulation of nuclear factor-1-dependent gene transcription.
  38. (1999). TGF-beta1 in liver fibrosis: an inducible transgenic mouse model to study liver fibrogenesis.
  39. The hydrophobic-hydrophilic balance of bile salts. Inverse correlation between reverse-phase high performance liquid chromatographic mobilities and micellar cholesterol-solubilizing capacities.
  40. The myofibroblast: one function, multiple origins.
  41. (1988). Transforming growth factor beta 1 positively regulates its own expression in normal and transformed cells.
  42. (1997). Transforming growth factor-beta 1 in chronic hepatitis C. J Viral Hepat.
  43. Transforming growth factor-beta and substrate stiffness regulate portal fibroblast activation in culture.
  44. (2008). Transient elastography to assess hepatic fibrosis in primary biliary cirrhosis. Aliment Pharmacol Ther.